Innate Pharma (IPHA) Stock Chart & Stock Price History $1.87 -0.07 (-3.61%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$1.88 +0.01 (+0.48%) As of 09/19/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Innate Pharma Stock Price Performance The Innate Pharma (IPHA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 16.89%, with a year-to-date return of 1.63%. In the past month, the stock has decreased 16.14%, reflecting recent market activity. As of the latest close, Innate Pharma traded at $1.87 with a market cap of $172.38 million and volume of 12,205 shares. Five years ago, the stock traded at $3.98, representing a 53.02% decrease over that period. At the time, it had a market cap of $304.64 million and a volume of 12,478 shares. Receive IPHA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-10.10%1 Month Performance-16.14%3 Month Performance+3.89%Year-To-Date Performance+1.63%1 Year Performance-16.89%5 Year Performance-53.02% IPHA Stock Chart for Sunday, September, 21, 2025 IPHA Chart by TradingView Innate Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/19/2025$1.94$1.87-3.61%$1.95$1.8212,205 shs$172.38 million09/18/2025$2.05$1.94-5.37%$1.99$1.9313,718 shs$178.83 million09/17/2025$2.08$2.05-1.44%$2.16$1.9666,225 shs$188.97 million09/16/2025$2.07$2.08+0.73%$2.19$2.0448,165 shs$191.74 million09/15/2025$2.00$2.07+3.25%$2.13$2.049,961 shs$190.35 million09/12/2025$2.02$2.00-0.74%$2.12$1.9318,294 shs$184.36 million09/11/2025$2.06$2.02-2.18%$2.06$1.965,233 shs$185.74 million09/10/2025$2.04$2.06+0.98%$2.06$1.9729,089 shs$189.90 million09/09/2025$2.04$2.04$2.05$2.032,133 shs$188.05 million09/08/2025$2.05$2.04-0.49%$2.04$1.9512,325 shs$188.05 million Get the Latest News and Ratings for IPHA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. 09/05/2025$2.10$2.05-2.38%$2.09$1.9016,208 shs$188.97 million09/04/2025$2.02$2.10+3.96%$2.16$2.0111,741 shs$193.59 million09/03/2025$2.08$2.02-2.93%$2.11$2.009,453 shs$186.20 million09/02/2025$2.13$2.08-2.07%$2.13$2.089,975 shs$191.83 million09/01/2025$2.13$2.13$2.19$2.161,849 shs$195.89 million08/29/2025$2.09$2.13+1.67%$2.19$2.161,849 shs$195.89 million08/28/2025$2.10$2.09-0.24%$2.20$2.093,328 shs$192.66 million08/27/2025$2.06$2.10+1.65%$2.10$2.0423,474 shs$193.12 million08/26/2025$2.20$2.06-6.49%$2.24$2.093,578 shs$189.99 million08/25/2025$2.25$2.20-2.04%$2.27$2.196,325 shs$203.17 million08/22/2025$2.23$2.25+0.90%$2.30$2.234,578 shs$207.41 million08/21/2025$2.23$2.23+0.22%$2.32$2.234,920 shs$205.56 million08/20/2025$2.28$2.23-2.41%$2.28$2.229,067 shs$205.11 million Related Companies OCS Stock Price Chart NAGE Stock Price Chart VALN Stock Price Chart GYRE Stock Price Chart GHRS Stock Price Chart VIR Stock Price Chart KURA Stock Price Chart RLAY Stock Price Chart BGM Stock Price Chart SANA Stock Price Chart Receive IPHA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IPHA) was last updated on 9/21/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innate Pharma S.A. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Innate Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
